1Dyckner T.Relation ofcardiovascular disease to potassium and magnesium defi ciencies.Am J Cardiol,1990,65:44K-46K.
2Teo KK, Yusuf S, Collins R, et al.Effects of intravenous magnesium in suspec t edacute myocardial infarction: overview of randomized trials.BMJ, 1991,303:14 99-1503.
3Woods Kl, Fletcher S, Roffe C, et al.Intravenous magnesium sulphate in suspe c tedacute myocardial infarction: results of the second Leicester intravenous Mag nesiumIntervention Trial (LIMIT-2).Lancet, 1992,339:1553-1558.
4ISIS-4 Collaborative Group.ISIS-4: a randomized factorial trial assessing ear lyoral captoprial, oral mononitrate, and intravenous magnesium sulfate in 58050 patientswith suspected myocardial infarction.Lancet, 1995, 345:669-685.
5The MAGIC Steering Committee Watertown, Mass.Rationale and design of the Mag nesium in Coronaries (MAGIC) study: A clinical trial to reevaluate the efficacy o f earlyadministeation of magnesium in acute myocardial infarction.Am Heart J, 2000,139:10-14.
6Shechter M, Hod H, Kaplinsky E, et al.Magnesium as alternative therapy in pa tients with acute myocardial infarction who are not candidates for thrombolytic t herapy.AmJ Cardiol, 1995,75:321-323.
7Shibata M, Ueshima K, Nakamura M, et al.Effect of magnesium sulfate pretreat m entand significance of mareix metalloproteinase-1 and interleukin-6 levels in c oronaryreperfusion therapy for patients with acute myocardial infarction.Angi ology, 1999,50:573-582.
8Naik P, Malati T, Ratnakar KS, et al.Cardioprotective effect of magnesium c hloridein experimental acute myocardial infarction.Indian J Exp Biol, 1999,37 :131-137.
